DMIIR Drugs Made In America Acquisition II Corp.: institutional ownership and insider trading
63 funds reported holding $3.31M of Drugs Made In America Acquisition II Corp. in their latest 13F filings; in Q2 2026 funds net bought $92.2K, with 5 new positions and 0 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
Famous investors holding DMIIR
- Izzy Englander (Millennium Management): $160K, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $72.7K, 0.0% of the portfolio
Largest institutional holders of DMIIR
- Magnetar Financial LLC — $228K
- TORONTO DOMINION BANK (TD, TDBCP) — $216K
- MMCAP International Inc. SPC — $216K
- MILLENNIUM MANAGEMENT LLC — $160K
- GLAZER CAPITAL, LLC — $152K
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND — $145K
- Polar Asset Management Partners Inc. — $124K
- TENOR CAPITAL MANAGEMENT Co., L.P. — $120K
- ARISTEIA CAPITAL, L.L.C. — $108K
- HGC Investment Management Inc. — $98.5K
Recent DMIIR insider trades
- Sep 26, 2025: Stockwell Lynn sold 7,966,667 shares ($0)
- Sep 26, 2025: Stockwell Lynn bought 700,000 shares ($0)
- Sep 26, 2025: Drugs Made In America Acquisition II LLC sold 7,966,667 shares ($0)
- Sep 26, 2025: Drugs Made In America Acquisition II LLC bought 700,000 shares ($0)
5%+ owners
- Drugs Made In America Acquisition II LLC: 10.2% (Schedule 13D, filed Oct 2, 2025)